Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
29 participants
INTERVENTIONAL
2020-05-20
2022-02-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The effect of a individually optimized resting environment will be tested against a standard resting environment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Day Time Activity Level in Inpatient Neurological Rehabilitation as Related to Functional Outcomes at Discharge, Length of Stay, Discharge Location, and Quality of Life: a Preliminary Study
NCT04065178
Motor Imagery in Rehabilitation After a Distal Radius Fracture
NCT01921062
Effect of Passive Gait Training on the Cortical Activity in Patients With Severe Brain Injury.
NCT00526500
Mobility and Activity Patterns in Hospitalised Severe Brain Injury
NCT05571462
Motor Activity and Its Barriers at the Early Phase Post-stroke in Acute Care Setting.
NCT04540978
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim is to identify differences in quality of rest as reflected by clinical evaluation, pulse rate, motor activity and autonomic balance between the optimized resting environment (ORE) and the standard resting environment (SR).
Method: A Randomized controlled time-series study. Randomization to either SR or ORE for each of the 9 resting periods during a three-day recording session. A period of three days will allow collection of sufficient data. This will also allow the analysis to take the random effects of time and weekday into account. Outcome measures will be differences in mean heart rate during daytime resting periods, aggregated measures of heart rate variability and proportion of resting minutes according to accelerometry.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Optimized resting environment
The optimized resting environment will consist of the following complex intervention.
* Technically assisted noise control in regards of alarms in the patient room
* Visual signing reminding staff that the patient is not to be disturbed during rest
* Individual optimization of room environment according to information received from relatives
* Individual optimization of room environment and positioning according to systematized knowledge on best practice in the intervention ward including auditory and visual stimuli
Optimized resting environment
Alarms from feeding pumps will be relayed to the nurse call system for all intervention periods. Alternatively meals will be timewise reorganized to not interfer with the intervention resting periods. Signs reminding staff not to disturb will be posted for all intervention periods.
For each patient the close team of rehabilitation professionals will agree upon a guideline suggesting the optimal resting environment for the specific patient. The guideline wil be based on knowledge gathered from relatives on pre-injury preferences. Furthermore, the guideline will be developed based on a toolbox of possible intervention representing best practice. The toolbox has been designed according to the categories of the International Classification of Functioning.
The intervention will designed individually for each patient.
Standard resting environment
Standard resting environment, will consist of a basic positioning either reclined in bed or reclined in wheelchair according to regular procedures of the ward.
Standard resting environment
The control condition, standard resting environment, will consist of a basic positioning either reclined in bed or reclined in wheelchair according to regular procedures of the ward. Pressure ulcers and positioning believed to induce pain will be avoided.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optimized resting environment
Alarms from feeding pumps will be relayed to the nurse call system for all intervention periods. Alternatively meals will be timewise reorganized to not interfer with the intervention resting periods. Signs reminding staff not to disturb will be posted for all intervention periods.
For each patient the close team of rehabilitation professionals will agree upon a guideline suggesting the optimal resting environment for the specific patient. The guideline wil be based on knowledge gathered from relatives on pre-injury preferences. Furthermore, the guideline will be developed based on a toolbox of possible intervention representing best practice. The toolbox has been designed according to the categories of the International Classification of Functioning.
The intervention will designed individually for each patient.
Standard resting environment
The control condition, standard resting environment, will consist of a basic positioning either reclined in bed or reclined in wheelchair according to regular procedures of the ward. Pressure ulcers and positioning believed to induce pain will be avoided.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \>= 18 years
* Relatives/Surrogate can give informed consent
* Classified as being ≤ 7 on the level of cognitive functions scale (also known as Rancho Los Amigos Scale)
Exclusion Criteria
* Terminal illness
* Spinal lesions
* Expected stay \< 3 weeks
* Paroxysmal Sympathetic Hyperactivity
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aalborg University
OTHER
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Simon Svanborg Kjeldsen
PhD Student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jørgen F Nielsen, MD DMSc
Role: STUDY_DIRECTOR
Hammel Neurorehabilitation Centre and University Research Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Regionshospitalet Hammel Neurocenter
Hammel, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-10-72-32-18
Identifier Type: OTHER
Identifier Source: secondary_id
1-10-72-32-18
Identifier Type: OTHER
Identifier Source: secondary_id
80
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.